Utah Medical Products (UTMD) Assets (2010 - 2026)

Utah Medical Products' Assets history runs 17 years deep, the most recent figure standing at $124.4 million for Q1 2026.

• In Q1 2026, Assets rose 1.52% year-over-year to $124.4 million; the TTM figure through Mar 2026 stood at $124.4 million (up 1.52% YoY), while the FY2025 annual figure was $122.5 million, changed 0.0% from the prior year.
• Assets was $124.4 million for Q1 2026 at Utah Medical Products, up from $122.5 million in the prior quarter.
• In the past five years, Assets ranged from a high of $135.5 million in Q4 2023 to a low of $116.1 million in Q2 2022.
• Historically, Assets has averaged $125.5 million across 5 years, with a median of $123.9 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Assets climbed 12.33% in 2023, then retreated 9.54% in 2025.
• A 5-year view of Assets shows it stood at $123.9 million in 2022, then climbed by 9.35% to $135.5 million in 2023, then decreased by 9.54% to $122.5 million in 2024, then climbed by 0.0% to $122.5 million in 2025, then rose by 1.5% to $124.4 million in 2026.
• The last three Assets figures came in at $124.4 million (Q1 2026), $122.5 million (Q4 2025), and $122.0 million (Q3 2025), per Business Quant data.